Mydecine Innovations Group Inc. (MYCOF) Corporate Media Kit

The Mindleap Platform Mindleap.com is the first international virtual health platform to include psychedelic integration. As a wholly-owned subsidiary of Mydecine, Mindleap has access to world-class research personnel who contribute directly to the build-out and improvement of this AI-powered dashboard, designed to help optimize one’s mental healing journey. Mindleap provides features for introduction and post-care integration that include fact-based education, 1:1 video coaching, trustworthy content, wellness guidance, and even a built-in health journal. Additionally, the technology enables healthcare professionals to remotely administer the majority of their protocol for psychedelic-assisted treatment, enhancing accessibility and scalability. Mindleap is also fully HIPAA and PIPEDA compliant, so everything is private and discreet. Mindleap currently has thousands of downloads and hundreds of licensed mental health coaches that can generate their own part-time or full-time income directly through the platform. As subscriber growth continues, Mindleap will expand its development team and broaden connections with leading healthcare organizations, practitioners, and researchers through its clinic program. The platform is available on iOS and Android, with an expanded web version on the way.

RkJQdWJsaXNoZXIy NDMyMDk=